Stock-based Compensation (Tables)

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Fair Value Assumptions for Stock Options

The following are the weighted-average assumptions used to calculate the grant-date fair values of stock option and SARs awards granted in the years ended December 31, 2025, 2024 and 2023:

	For the Years Ended December 31
	2025	2024	2023
Expected dividend yield	1.34%	1.22%	1.19%
Expected volatility	31.80%	30.89%	31.29%
Expected term	6.9 years	6.8 years	7.2 years
Risk-free interest rate	4.09%	4.23%	4.03%

Summary of Stock Option Activity

A summary of stock option activity for the year ended December 31, 2025 is presented below:

	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Options
Outstanding at January 1, 2025		338,352		$	89.21
Granted		4,364			59.86
Exercised		(2,473	)		42.17
Forfeited		(910	)		101.39
Outstanding at December 31, 2025		339,333			89.14		3.13	$	—
Vested or expected to vest at December 31, 2025		339,333			89.14		3.13		—
Exercisable at December 31, 2025		332,083			89.49		3.01		—

Summary of Stock Award Activity

A summary of stock award activity for the year ended December 31, 2025, is presented below:

	Shares			Weighted-Average Grant Date Fair Value
Stock Awards
Unvested at January 1, 2025		74,805		$	79.09
Granted		158,718			56.98
Vested		(27,852	)		89.52
Forfeited/modified due to change of assumptions		(45,525	)		59.18
Unvested at December 31, 2025		160,146			61.03

Summary of SARs Activity

The following is a summary of SARs activity for the year ended December 31, 2025:

	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
SARs
Outstanding at January 1, 2025		845,019		$	96.26
Granted		131,503			58.84
Exercised		(11,920	)		41.79
Forfeited		(21,692	)		79.08
Outstanding at December 31, 2025		942,910			92.12		4.98	$	—